Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Pharmacology|December 4, 2013
Drug-induced agranulocytosis in the Berlin case-control surveillance studyMatthias Huber, Frank Andersohn, Elisabeth Bronder, et al.
BMJ (Clinical Research Ed.)|June 8, 2010
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control studyChristel Renoux, Sophie Dell'aniello, Edeltraut Garbe, et al.
Pharmacoepidemiology and Drug Safety|April 11, 2016
Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registryChristoph Ohlmeier, Ingo Langner, Edeltraut Garbe, et al.
Drug Safety|February 15, 2017
The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone-Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case-Control StudyKathrin Jobski, Bianca Kollhorst, Edeltraut Garbe, et al.
Maturitas|November 11, 2008
Hormone replacement therapy use and the risk of strokeChristel Renoux, Sophie Dell'aniello, Edeltraut Garbe, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 15, 2013
Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly GermansChristoph Ohlmeier, Rafael Mikolajczyk, Wilhelm Haverkamp, et al.
Epilepsy Research|July 17, 2012
Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugsMichael Dörks, Ingo Langner, Antje Timmer, et al.
Oncology|March 18, 2011
Is guideline adherence the key to increased survival in patients with breast cancer?Falk Hoffmann, Frank Andersohn
Pharmacoepidemiology and Drug Safety|November 5, 2015
Characteristics and external validity of the German Health Risk Institute (HRI) DatabaseFrank Andersohn, Jochen Walker
Plos One|May 3, 2013
Twin and sibling studies using health insurance data: the example of attention deficit/hyperactivity disorder (ADHD)Ingo Langner, Edeltraut Garbe, Tobias Banaschewski, et al.
Pageof 14